Iterum Therapeutics plc (ITRMF) › Shareholders' EquityIterum Therapeutics plc (ITRMF) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: $14.95M2016: $22.67M2017: $39.49M2018: $71.62M2019: -$26.24M2020: -$50.56M2021: $50.23M2022: $28.00M2023: -$6.40M2024: -$4.08M-$4.08M2015Shareholders' Equity (USD)2024Fiscal YearShareholders' EquityChange YoY2024-$4.08M+36.3%2023-$6.40M-122.9%2022$28.00M-44.3%2021$50.23M+199.4%2020-$50.56M-92.7%2019-$26.24M-136.6%2018$71.62M+81.3%2017$39.49M+74.2%2016$22.67M+51.6%2015$14.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share